Palvella Therapeutics (PVLA) Expected to Announce Quarterly Earnings on Thursday

Palvella Therapeutics (NASDAQ:PVLA) is anticipated to announce its earnings results before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.58) per share for the quarter.

Palvella Therapeutics Price Performance

Shares of PVLA stock opened at $27.61 on Thursday. The business’s 50 day moving average is $18.23. Palvella Therapeutics has a 1 year low of $6.20 and a 1 year high of $29.27. The firm has a market capitalization of $309.81 million, a price-to-earnings ratio of -2.28 and a beta of 0.54.

Analysts Set New Price Targets

A number of brokerages have issued reports on PVLA. Cantor Fitzgerald began coverage on shares of Palvella Therapeutics in a research note on Wednesday, December 18th. They issued an “overweight” rating on the stock. HC Wainwright reissued a “buy” rating and set a $38.00 price target on shares of Palvella Therapeutics in a research report on Tuesday, February 11th. Scotiabank initiated coverage on shares of Palvella Therapeutics in a report on Friday, March 7th. They set a “sector outperform” rating and a $50.00 price objective on the stock. TD Cowen started coverage on shares of Palvella Therapeutics in a report on Wednesday, February 5th. They set a “buy” rating and a $44.00 price objective on the stock. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $39.00 price target on shares of Palvella Therapeutics in a research note on Wednesday, February 26th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $42.75.

Palvella Therapeutics Company Profile

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc, formerly known as Pieris Pharmaceuticals Inc, is based in WAYNE, Pa.